Displaying 2541 - 2560 of 4976
FTC Staff: Proposed Health Care Legislation in West Virginia Would Likely Be Anticompetitive and Harm Consumers
Date
Federal Trade Commission staff submitted written comments on the competitive impact of provisions in proposed legislation in West Virginia that would provide for “cooperative agreements” between...
Prepared Statement of the Federal Trade Commission On "Oversight of the Enforcement of the Antitrust Laws"
Date
By
Edith Ramirez, Former Chairwoman
Matter Number
P859910
File
Text of the Commission Testimony
(95.73 KB)
FTC Chairwoman Ramirez Testifies Before Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights
Date
Testifying on behalf of the Federal Trade Commission before the U.S. Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, Chairwoman Edith Ramirez outlined how effective...
1603001 Informal Interpretation
Date
Rule
801.10, 801.30
If multiple open market purchases are made on the same day, the buyer need not (but may) revalue its holdings more than once daily.
File
Original Image
(69.09 KB)
Report
Quarterly Litigation Status Report- March 2016
Date
File
Quarterly Litigation Status Report (March 2016)
(210.87 KB)
FTC Puts Conditions on Drug Manufacturer Hikma Pharmaceuticals PLC’s Proposed Acquisition of Roxane Laboratories Inc. and Boehringer Ingelheim Roxane, Inc. from Boehringer Ingelheim Corporation
Date
Drug manufacturer Hikma Pharmaceuticals PLC will sell the rights and assets for two generic drugs, and relinquish its U.S. marketing rights to a third generic drug, in order to settle FTC charges that...
FTC Approves Modified Consent Order for Mylan N.V.
Date
The Federal Trade Commission has approved a modified final order settling charges that Mylan N.V.’s proposed hostile takeover of Perrigo Company plc would harm competition. Because Mylan failed to...
Mylan N. V., In the Matter of (Perrigo Company), In the Matter of
Mylan N.V. agreed to sell the rights and assets related to seven generic drugs in order to settle FTC charges that its proposed acquisition of Perrigo Company plc would be substantially reduce competition in the markets for those drugs if the merger proceeded as originally proposed.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
151 0129
C-4557
1602002 Informal Interpretation
Date
Rule
801.11
If a natural person has an annual statement of income and does not control any other entities - end of analysis. Whatever is on the income statement rules for purposes of determining size of person...
File
Original Image
(48.01 KB)
1602001 Informal Interpretation
Date
Rule
802.63, Size of Transaction
For purposes of calculating the size of transaction, debt that is acquired post-bankruptcy announcement and that will be cancelled/forgiven in exchange for equity in target must be included. This is...
File
Original Image
(59.78 KB)
FTC Requires Drug Marketer Hikma Pharmaceuticals PLC to Divest Rights to Five Generic Injectable Drugs as a Condition of Acquiring Certain Drug Products from Ben Venue Laboratories, Inc.
Date
The Federal Trade Commission will require generic drug marketer Hikma Pharmaceuticals PLC to divest its rights and interests in five generic injectable pharmaceuticals, as part of a settlement...
FTC Puts Conditions on Generic Drug Marketer Lupin Ltd.’s Proposed Acquisition of Gavis Pharmaceuticals LLC
Date
Generic drug manufacturers Lupin Ltd. and Gavis Pharmaceuticals LLC will sell the rights and assets for two generic drugs, one used to treat bacterial infections and the other to treat ulcerative...
Federal Antitrust Agencies Submit Joint Statement Encouraging Massachusetts to Consider Expanding Treatment Options for Glaucoma Patients
Date
In response to a request by Massachusetts State Representative Bradley H. Jones, the Federal Trade Commission and the Department of Justice’s Antitrust Division have submitted a statement encouraging...
FTC Amicus Brief Urges Appeals Court to Correct District Court Holding that Proving Injury-in-Fact Is Necessary to Establish an Antitrust Violation
Date
The Federal Trade Commission filed an amicus brief in the U.S. Court of Appeals for the First Circuit urging the court to correct the district court’s holding that a plaintiff must prove an injury-in...
In re Nexium (Esomeprazole) Antitrust Litigation
Date
Citation Number
15-2005, 15-2006, 15-2007
Federal Court
U.S. Circuit Court of Appeals for the First Circuit
Brief of the Federal Trade Commission arguing that the district court committed legal error by conflating two distinct analyses under antitrust law: the existence of an antitrust violation, which...
File
Text of the Amicus Brief
(267.26 KB)
FTC Staff: West Virginia Should Consider the Competitive Impact of Legislation Affecting Advanced Practice Registered Nurses
Date
Federal Trade Commission staff submitted written comments on the competitive impact of a legislative proposal to modify the supervision requirements imposed on Advanced Practice Registered Nurses...
FTC Submits Fiscal Year 2017 Budget Request, Performance Plan, and Fiscal Year 2015 Performance Report to Congress
Date
The Federal Trade Commission has submitted to Congress its Fiscal Year 2017 budget request, which includes the FY 2017 Budget Overview Statement, Performance Plan for FY 2016 and FY 2017, and...
FTC Announces Schedule for Reviewing Regulations
Date
As part of the Federal Trade Commission’s systematic review of all current FTC rules and guides, the agency is announcing a modified 10-year regulatory review schedule. To ensure that its rules and...
Displaying 2541 - 2560 of 4976